Region Zealand Report issue

Government Phase 2 Phase 4

Organization Overview

First Clinical Trial
2018
NCT03778554
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Epilepsihospitalet Filadelfia | Region Zealand